0Q15 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abbott Laboratories

Watchlist Manager

Watchlist

Price: 93.95 USD -0.33% Market Closed

Market Cap: $164.5B

A	Abbott Laboratories LSE:0Q15	US
T	Telecom Italia SpA OTC:TIAIY	IT
	Chorus Ltd NZX:CNU	NZ
G	Givaudan SA LSE:0QPS	CH
A	Amerant Bancorp Inc NYSE:AMTB	US

Profitability Summary

Abbott Laboratories's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

56%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

55% > 56%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

17% > 19%

Healthy Net Margin

14%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

14% > 14%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

15%

Declining Free Cash Flow Margin

16% > 16%

Positive ROE

12%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

10% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.